Live Breaking News & Updates on Hd Immune Gmbh Hdi Biotechnology Antibody Treatments Huntingtons Disease Stefan Bartl Lionel Wightman Affiris Ag Austria Wirtschafts Service Austrian Centre Of Industrial Neurodegenerative Monogenetic Disorder Mutant Huntingtin Protein Mthtt Preclinical Data Preseed Financing Round Institute Molecular

Stay updated with breaking news from Hd immune gmbh hdi biotechnology antibody treatments huntingtons disease stefan bartl lionel wightman affiris ag austria wirtschafts service austrian centre of industrial neurodegenerative monogenetic disorder mutant huntingtin protein mthtt preclinical data preseed financing round institute molecular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HD Immune GmbH Foundation and Publication of Latest PreClinical Data

HD Immune GmbH HDI a privately held biotechnology company developing novel antibody treatments for Huntingtons Disease announces commencement of operations by its two founders Dr. Stefan Bartl and Dr. Lionel Wightman. ....

Stefan Bartl , Lionel Wightman , Austria Wirtschafts Service , Austrian Centre Of Industrial Biotechnology , University Of Natural Resources , Life Sciences , Institute Of Molecular Biotechnology , Austrian Business Angel , Austrian Centre , Industrial Biotechnology , Molecular Biotechnology , Natural Resources , Media Contact , Hd Immune Gmbh Hdi Biotechnology Antibody Treatments Huntingtons Disease Stefan Bartl Lionel Wightman Affiris Ag Austria Wirtschafts Service Austrian Centre Of Industrial Neurodegenerative Monogenetic Disorder Mutant Huntingtin Protein Mthtt Preclinical Data Preseed Financing Round Institute Molecular ,